ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally
invasive medical devices for vascular access, surgery, peripheral
vascular disease and oncology, today announced that executive management
will present at the following investor conferences in May 2011:
The Deutsche Bank 36th Annual Health Care Conference in Boston. Jan
Keltjens, President and Chief Executive Officer, is scheduled to
present an overview of the Company on Monday, May 2, 2011, at 3:30
Bank of America Merrill Lynch Health Care Conference in Las Vegas. Mr.
Keltjens is scheduled to present an overview of the Company on
Tuesday, May 10, 2011, at 4:20 p.m. PT.
To listen to the audio web cast of a presentation during or after the
event, please visit: http://investors.angiodynamics.com.
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access, surgery, peripheral vascular disease and oncology.
AngioDynamics' diverse product lines include market-leading ablation
systems, vascular access products, angiographic products and
accessories, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
D. Joseph Gersuk,
CFO, 800-772-6446 ext. 1608
Doug Sherk, 415-896-6820 (Investor Relations)
Gin, 415-896-6820 (Investor Relations)
Chris Gale, 646-201-5431 (Media)
Source: AngioDynamics, Inc.
News Provided by Acquire Media